The latest immunotherapy news and developments
Microbiome mastery: Enhancing cancer care
The microbiome could be the key to identifying individuals who can benefit from combination immunotherapy…
The latest immunotherapy news and developments
The microbiome could be the key to identifying individuals who can benefit from combination immunotherapy…
People who have had a kidney transplant are at high risk for developing skin cancers.…
Drugs that target a receptor on immune cells called activin receptor 1C may combat tumour-induced…
A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune…
Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumour at the time of…
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center, USA, have built and demonstrated the…
Scientists at the UC San Francisco (UCSF) and Northwestern Medicine, USA, may have found a…
Through an analysis of tumour samples collected over time from patients with advanced melanoma, a…
For the first time in fifty years, results from a phase 3 randomised, placebo-controlled trial…
The dual immunotherapy combination of nivolumab and ipilimumab reduced the risk of disease progression or…